Past events
Day |
August 4, 2021, 18:00 - 19:30 |
---|---|
Place | Online participation via Zoom |
Contents |
Moderators and panelistsSpeakers Primary objectives and outcomesThe end of the COVID-19 pandemic remains out of sight. To overcome challenges in these times of uncertainty, Japan set the goal of leaving no one's health behind. JICA is taking a holistic approach to address issues related to the pandemic and health security in partner countries by focusing on prevention, precaution and treatment. Using this approach, it hopes to contribute to the protection of people's lives as the urgent target and build increasingly resilient societies. Content of the discussionsIn this seventh webinar, Prof.NAKAYAMA gave an overview of the latest situation regarding vaccination of COVID-19 vaccination. He presented the infection mechanisms of SARS-CoV-2, the characteristics of the new nucleotide-based vaccines, and the efficacy and adverse events of various COVID-19 vaccines, among others. A total of 494 participants from 68 countries participated in the webinar. Many questions were raised, such as antibody responses after vaccines, vaccination for people previously infected with COVID-19, concerns for third doses of COVID-19 vaccines, and vaccination for children. Prof.NAKAYAMA emphasized the importance of the appropriate understanding of science and scientific evidence for COVID-19 vaccination. |
Flyer | |
Organizer |
Japan International Cooperation Agency (JICA) |
Language |
English/French |
Video | |
Presentation Materials | |
Inquiry | JICA Ogata Research Insititute for Peace and Development (Ms.Yamamoto) E-mail:orifhd@jica.go.jp |
Apply |
This event has ended. |